Evaluation of the Efficacy of Dimercapto Chelating Agents for the Treatment of Systemic Organic Arsenic Poisoning in Rabbits
- 1 July 1990
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 9 (4) , 215-220
- https://doi.org/10.1177/096032719000900403
Abstract
1 The standard drug for the treatment of arsenic poisoning is BAL (dimercaprol). BAL possesses marked side-effects and a low safety ratio, drawbacks which new BAL analogues, DMPS and DMSA, do not possess.Keywords
This publication has 9 references indexed in Scilit:
- Comparative acute systemic toxicity of sodium arsenite and dichloro(2-chlorovinyl)arsine in rabbitsToxicology, 1988
- Experimental Approaches to the Design and Assessment of Antidotal ProceduresPublished by Elsevier ,1988
- Role of 2,3-Dimercaptosuccinic Acid in the Treatment of Heavy Metal PoisoningMedical Toxicology, 1986
- DMSA and DMPS-Water Soluble Antidotes for Heavy Metal PoisoningAnnual Review of Pharmacology and Toxicology, 1983
- Anti-lewisite activity and stability of Meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acidLife Sciences, 1982
- Quantitative studies of the effect of antagonists on the acute toxicity of organophosphates in ratsBritish Journal of Pharmacology, 1970
- CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION 1Journal of Clinical Investigation, 1946
- CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). I. THE SYSTEMIC TREATMENT OF EXPERIMENTAL ARSENIC POISONING (MAPHARSEN, LEWISITE, PHENYL ARSENOXIDE) WITH BAL 1Journal of Clinical Investigation, 1946
- CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN 1Journal of Clinical Investigation, 1946